Across TCGA pan-cancer cohorts, MIR320D2 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR320D2 data layer compared with 2 for mutation status.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MIR320D2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR320D2 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BRCA, OV, and TGCT are the cancer types where MIR320D2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.128	0.579	<.001	87	view →
OV	DFS	Tertile	All	0.337	0.545	.008	54	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.374	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR320D2 tumor-vs-normal RNA expression · all MIR320D2 data types